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The heat shock response (HSR) is a cellular response to diverse environmental
and physiological stressors resulting in the induction of genes encoding molecular
chaperones, proteases, and other proteins that are essential for protection and
recovery from cellular damage. Since different perturbations cause accumulation of
misfolded proteins, cells frequently encounter fluctuations in the environment which
alter proteostasis. Since tumor cells use their natural adaptive mechanism of coping
with stress and misfolded proteins, in recent years, the proteostasis network became
a promising target for anti-tumor therapy. The membrane is the first to be affected by
heat shock and therefore may be the first one to sense heat shock. The membrane also
connects between the extracellular and the intracellular signals. Hence, there is a “cross
talk” between the HSR and the membranes since heat shock can induce changes in
the fluidity of membranes, leading to membrane lipid remodeling that occurs in several
diseases such as cancer. During the last decade, a new possible therapy has emerged
in which an external molecule is used that could induce membrane lipid re-organization.
Since at the moment there are very few substances that regulate the HSR effectively, an
alternative way has been searched to modulate chaperone activities through the plasma
membrane. Recently, we suggested that the use of the membrane Transient Receptor
Potential Vanilloid-1 (TRPV1) modulators regulated the HSR in cancer cells. However,
the primary targets of the signal transduction pathway are yet un-known. This review
provides an overview of the current literature regarding the role of HSR in membrane
remodeling in cancer since a deep understanding of the membrane biology in cancer
and the membrane heat sensing pathway is essential to design novel efficient therapies.
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THE HEAT SHOCK RESPONSE AND CANCER
The heat shock response (HSR) is a highly evolutionary conserved mechanism that is initiated by
environmental and physiological stressors such as heat, oxidative stress, heavy metals, toxins, and
bacterial infections, and is essential for the survival in a stressful environment (Akerfelt et al., 2010).
The HSR is a cell-autonomous response and is thought to be induced by the presence of misfolded
proteins. The cellular protein homeostasis (“proteostasis”) network was described recently in
one of Morimoto’s latest reviews as “a conserved cellular machinery to support all aspects of
protein biogenesis, to adapt to a complex and changing environment, and to determine organismal
lifespan.” Proteostasis is the process that integrates signals and regulates flux from protein synthesis,
folding, transport, and degradation (Brandvold and Morimoto, 2015). The chaperone network
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assists in maintaining protein functionality and counteracts
intrinsic and extrinsic forces that perturb protein folding. Hence,
molecular chaperones maintain cellular, tissue, and organismal
health (Brandvold and Morimoto, 2015).
Mutations, inflammation, neurodegenerative, and cancer
diseases are associated with abnormal cytosolic and endoplasmic
Reticulum (ER) proteostasis, hence, with changes in the
expression of chaperones (Brandvold and Morimoto, 2015).
Chaperones are a family of highly conserved proteins that
recognize nascent polypeptides and folding intermediates and
whose function is to guide proteins to their native state.
Among them is the most highly evolutionary conserved, the
Heat Shock Protein 70’s (Hsp70) family (Bukau and Horwich,
1998; Dufey et al., 2015). Hsp70 binds to its substrates
through hydrophobic residues in an ATP-dependent manner.
This binding is accompanied by Co-chaperones such as: Hsp40
(Bukau and Horwich, 1998). Hsp70 also binds to mutant proteins
that may accumulate in the cytoplasm and hence enabling the
accumulation of cancer mutant proteins, such as p53 (Jäättelä
et al., 1998; Voisine et al., 2010). Both Hsp70 and Hsp90 interact
and regulate many transcription factors, signaling molecules,
and kinases that are related to cancer, including NF-κB, p53, v-
Src, Raf1 Akt, and steroid hormone receptors (Li et al., 2009).
Hence, there is evidence that transformed cells express higher
levels of Hsps compared to non-transformed cells (Jäättelä et al.,
1998) and that Hsp70 plays a role in cancer development, since
high levels of Hsp70 is also thought to increase the resistance of
tumor cells to apoptosis (Jäättelä et al., 1998) or to chemotherapy
(Mosser and Morimoto, 2004). Therefore, the anti-apoptotic role
of the chaperones, mainly in cancer cells, may “contribute” to the
increased resistance to chemo- and radiotherapy treatments.
Overexpression of Hsp70 can inhibit multiple pathways of
cell death, including both intrinsic and extrinsic apoptosis
(Murakami et al., 2015). Hsp70 is known for its ability to bind
the pro-apoptotic Bcl-2 family member BAX, thus preventing
its activation and translocation to the mitochondria (Murakami
et al., 2015). Hsp70 also binds the death receptors DR4 and
DR5 of the extrinsic apoptotic pathway. Hence, inhibition of
cytosolic Hsp70 has emerged as a promising anti-cancer therapy
(Murakami et al., 2015).
We have previously found that Hsp70 acts at multiple
control points of the apoptotic pathways, including inhibition
of several activation of caspases, prevention of cytochrome c
release and regulation of the apoptosome by directly binding
to Apaf-1 (Aschkenasy et al., 2011). Hence, since Hsp70 plays a
general protective role against programmed cell death, increased
expression of Hsp70 correlates with cancer progression and
metastasis.
In tumor cells, ER stress also occurs by micro-environmental
changes such as hypoxia, nutrient deprivation, acidosis, calcium
depletion, glucose deprivation, and reactive oxygen species
(ROS) production (Dufey et al., 2015). Although the ER
chaperone network also suppresses tumorigenesis, [depending
on the tumor context (van Vliet et al., 2015)], these stressful
perturbations promote the Unfolding Protein Response (UPR)
and the release of several factors that induce stress adaptation and
cell survival, and might also increase resistance to chemotherapy
(Dufey et al., 2015). For instance, ER chaperones such as the
immunoglobulin heavy-chain Binding Protein (BiP) is one of the
factors initiating tumor growth, becoming detectable on the cell
surface of many cancer cells (Dufey et al., 2015). We know that
BiP dissociated from protein kinase R -like ER kinase (PERK),
inositol-requiring enzyme 1 (IRE1) and activating transcription
factor 6 (ATF6). ER homeostasis is achieved by PERK translation
as well as phosphorylation of the initiation factor 2α (eIF2α)
in order to reduce influx into the ER (van Vliet et al., 2015).
Interestingly, others have found that PERK also utilizes lipid
kinase actvity, using diacylglycerol (DAG) as a substrate to
generate phosphatidic acid (PA). This phosphorylation process
was found to be correlated with the phosphorylation of Akt and
activation of mTOR, thus, hinting that PERK has also a central
role in cellular migration, metabolism, and cell growth. Due
to the fact that PA is produced by PERK further points to its
central role in membrane and actin remodeling and in several
pro-survival pathways (van Vliet et al., 2015).
Recent works have also shown the role of PERK in ER calcium
signaling, since it has been linked to calreticulin (Ca2+ dependent
phosphatase, store operated calcium entry), as exemplified in
a study done in colon cancer cells. It was previously shown
that lower ER Ca2+ levels promote pre-apoptotic calreticulin
exposure on the surface of cancer cells treated with chemotherapy
(van Vliet et al., 2015).
REGULATION OF THE HEAT SHOCK
RESPONSE—THE CLASSICAL PATHWAY
The HSR is regulated at the transcriptional level by the activities
of a family of heat shock transcription factors (HSFs). The
mammalian HSF family consists of four members: HSF1, HSF2,
HSF3, and HSF4 (Akerfelt et al., 2010). Different HSFs possess
unique and overlapping functions, consisting of tissue specific
patterns having various post-translational modifications (PTMs)
(Akerfelt et al., 2010). Heat Shock Factors (HSFs) recognize and
bind to heat shock elements (HSEs) present in the promoter
of heat shock genes. Among the human HSF genes, HSF1 is
the most essential for the HSR and is constitutively expressed
in most tissues and cell types (Akerfelt et al., 2010).For many
years, the consensus of the activation of the HSR was that under
normal conditions of cell growth, HSF1 exists in a repressed state
associated with Hsp90, Hsp70, and Hsp40 and distributed in a
negatively regulated state as an inert monomer in the cytoplasm.
Upon exposure to a variety of stresses such as heat shock, or
oxidative stress, HSF1 is liberated, trimerizes, and accumulates in
the nucleus (termed the “classical” pathway). HSF1 trimers bind
with high affinity to the HSE. (Barral et al., 2004;Westerheide and
Morimoto, 2005; Soto and Estrada, 2008; Voisine et al., 2010).
However, there is also an interplay between HSFs, since HSF2
also binds to the promoter of HSP genes. HSF2 depends on HSF1
for its stress-related functions (Elsing et al., 2014). However,
HSF2 modulates HSP gene expression, implying that HSF2 has
a role in the regulation of HSR. It is known that HSF2 also
plays a role in the developmental processes (Elsing et al., 2014).
The expression of HSF2 in the testes is regulated by microRNA
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mir-18i (Björk et al., 2010). Mir-18 is also a member of the mir-
17-92 oncomir-1 cluster and has been proposed to participate
in tumor progression, as was demonstrated in a mouse model
of colon cancer (Dews et al., 2006). HSF2 has an active role
during mitosis and a decreased HSF2 expression during mitosis
was shown to protect cells against preteotoxicity and apoptosis
(Elsing et al., 2014). HSF2 deficient cells have also shown elevated
levels of survival during acute heat stress, with fewer mitotic
errors (Björk et al., 2010). Further, it was suggested that declining
levels of HSF2 during mitosis in several cell lines is accompanied
with induction of Hsp70 (Elsing et al., 2014). Hence, it is tempting
to speculate that controlling the levels of HSF2 in cancer could
affect Hsp70 expression. Others have demonstrated that HSF2
is a potent suppressor of tumor progression in prostate cancer
by directing and regulating epithelial plasticity (Dews et al.,
2006). An interesting fact is that HSF2 was found to regulate
cell movement affecting actin cytoskeleton signaling (Björk et al.,
2016).
Among the well-known substances that were found to affect
the classical pathway activating or inhibiting the HSR are:
Celastrol, Arylsulfanyl as well as Pyrazolones (Llauger et al.,
2005). Arylsulfanyl, for instance, is a purine-scaffold class
inhibitor (Llauger et al., 2005), and a series of 8-arylsulfanyl,
-sulfoxyl, and –sulfonyl adenine members of the purine class
were synthesized and evaluated as inhibitors of chaperones;
they bind to Hsp90, (a highly abundant chaperone within
the cells), with moderate affinity and initiate cellular effects
that mimic 17-allyl-aminodesmethoxy- geldanamycin; (17AAG).
This inhibitor, (17AAG) has entered clinical trials in cancer
patients in the US and UK and has shown early advantage of
therapeutic activity when administered alone or in combination
with the chemotherapeutic docetaxel. However, 17AAG has a
limited solubility and cumbersome formulation. It also exhibits
dose dependent liver toxicity caused by the benzoquinone
functionality (Chang et al., 2014).
Celastrol, which activates the HSR and elevates Hsp70 levels,
inhibits the IKK-NF-κB cell signaling pathway, by inhibiting
directly the IKKα and IKKβ and inactivating the Cdc37 and p23
proteins (Salminen et al., 2010).
Due to the biochemical and structural differences between
Hsp90 and Hsp70, the targeting of Hsp70 has been less developed
(Goloudina et al., 2012). Furthermore, inhibition of Hsp90 alone
could also be associated with a compensatory increase in cytosolic
Hsp70 levels leading to tumor resistance (Goloudina et al., 2012).
Therefore, it is important to develop inhibitors of Hsp70 that will
be used in conjunction with Hsp90 inhibitors.
Substances that inhibit Hsp90, such as 17-AAG, enhance
the binding of GRP75 (a member of the Hsp70) to p53,
resulting in the “holding” of p53 in the cytoplasm. However,
inhibition of GRP75 using MKT-077 (rhodacyanine), an Hsp70
inhibitor, initiates disruption of the 17-AAG-induced GRP75-
p53 complex. Released p53 translocates into the nucleus and
triggers transcription of apoptosis-related genes (Guo et al.,
2014), as was recently found in a liver cancer xenograft model
(Guo et al., 2014). However, MKT-077 is rapidly metabolized,
which limits its usability. Therefore, analogs of MKT-077 were
designed with greater stability. One of suchmolecules is JG-98 (Li
et al., 2013), which is about three-foldmore active thanMKT-077.
JG-98, moderately destabilized Akt1 and Raf1, which are known
to interact with each other and thus to stimulate proliferation
(Zimmermann and Moelling, 1999).
Peptide inhibitors were also developed. One of them, ADD70,
a domain of Apoptosis-inducing factor (AIF) interacts with the
substrate binding domain (SBD) of Hsp70, with a promising anti
cancer activity when transfected into tumor xenografts in mice
(Murphy, 2013).
Gudkov discovered the 2-phenylethynesulfonamide (PES),
a compound that inhibits the trafficking of p53 to the
mitochondria, NF-kB activation and causes ribosome pausing as
well as decreasing protein translation (Murphy, 2013). Hence,
PES could serve as a potent Hsp70 inhibitor for the treatment
of cancer.
PES was also proposed to bind to the SBD of heat-inducible
Hsp70. PES also demonstrated moderate inhibitory effects on the
chaperone action of the constitutive Hsc70 and the heat inducible
Hsp70. However, it was suggested that PES may also interact with
low affinity and un-specifically with the SBD of Hsp70 (Schlecht
et al., 2013).
Others have used the structure of HSC70 –BAG-1 interaction
to design analogs that bind to the ATP-binding pocket
(Murphy, 2013), such as the ATP-analog VER-155008, which
inhibits the proliferation of various cancer cell lines (Murphy,
2013).
However, since Hsp70 binds ATP about 300 times more
tighter than Hsp90 and with the Hsp70’s site being more exposed
to solvent (Brandvold and Morimoto, 2015), we should question
whether there is an alternative way for modulating chaperones
activity. In several diseases such as cancer, the induction of the
HSR is followed by the remodeling of membrane lipids (Gombos
et al., 2011). So, is it possible to regulate the HSR in cancer
through the use of a treatment that affects membrane lipid
re-organization?
THE PLASMA MEMBRANE AND CANCER
The biological membrane acts as a selectively permeable barrier
(Maxfield and Tabas, 2005), allowing the functions of organelles
as well as the transmembrane electro-chemicals (Maxfield
and Tabas, 2005). The biophysical properties of membranes
such as fluidity is intimately linked to the composition and
structural organization of membrane lipids (Maxfield and Tabas,
2005). pH, ionic strength, temperature, water concentration, or
lateral pressure and the temperature modulate the membrane
fluidity (Lladó et al., 2014).Today, we know that there is
heterogeneity in lipid and protein populations in the plasma
membrane. This complexity is present in lipid rafts, caveolae,
and receptors/channel clusters, since many proteins such as
channels, receptors, and enzymes, interact with lipids of the cell
membranes (Lladó et al., 2014).
Changes in lipid composition or modification in the structure
of the cell membranes have been described in a number
of pathologies (Maxfield and Tabas, 2005). Several oncogenic
processes are initiated through the plasma membrane, such
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as adhesion, proliferation and migration (Maxfield and Tabas,
2005). Protein-lipid interactions are modified following the
disease state as well (Maxfield and Tabas, 2005). In cancer
cells, there are changes in lipid composition that are related to
the malignancy of the tumor; there is elevation of fatty acid
biosynthesis in order to generate new membranes due to an
increased proliferation ratio. With regard to the breast tissue
it is known that the fatty acid and phospholipid profiles are
also altered in the healthy tissue areas surrounding the tumor
(Maxfield and Tabas, 2005).
One of the most important lipid regulators of the cell
membrane is Cholesterol (Maxfield and Tabas, 2005).
One important lipid pathway modified in cancer is the
cholesterol metabolism, since esterification of cholesterol
is linked to an elevation of the cell cycle progression and
tumor growth. Changes in the composition of lipids can affect
signal transduction and membrane trafficking; For instance,
certain lipids, specifically phosphoinositides, organize signal-
transduction processes located within the cells (Maxfield and
Tabas, 2005).
Reduced cholesterol is associated with reduced actin-
dependent protrusions and with reduced activation of the small
GTPase Rac in cells (Maxfield and Tabas, 2005). The Rho family
GTPases are central to various responses in the cell through
the regulation of cytoskeleton organization, adhesion dynamics
and membrane trafficking, cell cycle progression and survival
(Moissoglu et al., 2014). Their dysregulation promotes several
diseases as well as cancer (Moissoglu et al., 2014). For years,
it has been suggested that Rac1 is associated with cholesterol-
rich membranes, lipid rafts (Moissoglu et al., 2014). However,
recently, it has been demonstrated that Rac is present in
disordered domains and that Rac translocates mainly to the
domain boundaries. It was also observed recently that Rac is
selectively inactivated in non-raft regions (Moissoglu et al., 2014).
A high percentage of the approved drugs for treating cancer
are directed toward the plasma membrane. Among them are
drugs that are targeted to the tyrosine kinase receptors VEGF,
HGFR, MAP kinase 1, and serine threonine-protein kinase
B-raf (Ziegler et al., 2014). Ziegler et al. managed to screen
target proteins that are present in the plasma membrane in
breast cancer cell lines (Ziegler et al., 2014): They found the
expression of the tyrosine kinase receptors that initiate signal
transduction pathways critical to the development of normal
cells. However, when de-regulated, they promote proliferation
and metastasis (Ziegler et al., 2014). Other proteins found in the
plasma membrane, such as adhesion molecules, are crucial for
interactions with neighboring cells and the extracellular matrix.
These molecules are highly expressed in the plasma membranes
of several breast cancer cell lines. Among them are the cadherins,
catenins, and integrins. Further, tumor progression is correlated
with changes in the cytoskeletal protein profile and organization.
The changes are thought to be initiated at the cellular surface
level of the transformed cell that loses polarity and adhesion, with
amorphous properties and migratory capabilities (Ziegler et al.,
2014).
Some cancer cells have a lipogenic phenotype, in which
they synthesize fatty acids for plasma membrane requirements.
Lipogenesis is thought to be correlated with chemoresistance
and protection from various insults, in order to increase survival
under stressed conditions. Such insults could be mechanical
stress and immune system attack, both known to cause plasma
membrane injury and stressors that are faced by progressing
tumors (Ziegler et al., 2014).
THE PLASMA MEMBRANE—THE FIRST
SHIELD COMBATING THE HEAT SHOCK
RESPONSE
Over the last decade, a parallel paradigm has matured, placing
the plasma membrane at the forefront and main effector of
the HSR. The “membrane thermosensor” theory suggests that
heat shock can induce changes in the fluidity of membranes,
leading to remodeling of the membrane and re-organization
of the membrane lipids. Such changes occur in cancer or
neurodegenerative diseases, diet and during aging (Gombos et al.,
2011), thus, influencing stress sensing cellular pathways that up-
regulate heat shock proteins (Gungor et al., 2014). Since the
membrane lipid phase structure is dependent on the thermal
behavior of themembrane, the use of non-proteotoxic membrane
fluidizers revealed that changes in the membrane surface are the
first initiated events of the heat sensing pathway signaling (Török
et al., 2014). Hence, HSP levels may increase without apparent
protein denaturation or aggregation in the cell, such as when
following a very mild temperature increase or in the presence
of membrane-interfering compounds, such as Arimoclomol and
Benzyl alcohol (deMarco et al., 2005; Saidi et al., 2005, 2009; Vigh
et al., 2005).
Chemicals such as: Bimoclomol, Arimoclomol, Benzyl
alcohol, HA (Hydroxyl amine) derivates, were found not to
induce a “classical” elevation of the HSR. We and others have
shown that these membrane fluidizers cause induction at non-
inducing temperatures in plants and bacteria (Vígh et al., 1997;
Balogh et al., 2005).
While these findings strengthen the hypothesis that
membranes are “sensors” of environmental stress, through
the modulation of microdomains (Escribá et al., 2008; Horváth
et al., 2008), a number of investigators have explored “alternative”
mechanisms by which a cell membrane receptor that is activated
by external molecules can transmit signals that will eventually
up-regulate the expressions of chaperones. A recent work in
plants by Saidi et al. (Balogh et al., 2005) suggests that a mild
temperature elevation or treatment with Hsp90 inhibitors
induced the HSR via a transient influx of calcium through a
channel in the plasma membrane. These experiments in plants
suggest that early sensing of mild temperature occurs at the
plasma membrane level and may be independent of the cytosolic
protein unfolding machinery.
It was previously demonstrated that Hsp70 translocates into
the plasma membrane after stress through the non-classical
ER/Golgi transport pathway (Murakami et al., 2015; Multhoff
et al., 1995). Murakami and others, suggested early in 1995
that lipid anchorage appears to be the most likely explanation
for Hsp70 cell-surface localization (Murakami et al., 2015) and
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that the localization of surface Hsp70 is dependent on the
cholesterol content of the membrane. It was also suggested
that membrane Hsp70 may be associated with “lipid rafts”
(Vega et al., 2008; Nimmervoll et al., 2015). Several researchers
speculated that the possible mechanism behind this concept is
that Hsp70 is transported to the plasma membrane by fusion
of Hsp70–lipid vesicles with the plasma membrane. Recently,
researchers have hypothesized that membrane Hsp70 may have
a role in the endocytosis process in cancer (Nimmervoll et al.,
2015); Elevated levels of membrane Hsp70 in melanoma cells
through overexpression of the Hsp70 encoding gene induced
clathrin- independent endocytosis. They further suggested that
a fraction of the membrane Hsp70 that is localized in lipid
rafts is oligomerized and clustered in the plasma membrane and
that the Hsp70 membrane organization stimulated endocytosis
(Nimmervoll et al., 2015).
The relevant pathways and mechanisms of the clathrin-
independent endocytosis, relies on Calmodulin, Phospholipase
D, PKA, PKC that are also known to be linked to calcium
regulation. Small GTPases such as RhoA, Rac1, and ARF6
(Sandvig et al., 2011) are also involved. Among them, Rac1
was found to regulate actin polymerization and signals from
integrins and growth factor receptors, therefore, also regulating
cell transformation, tumor invasion, and metastasis (Gungor
et al., 2014).
IS THERE ANOTHER PATHWAY? IS THERE
A SPECIFIC “HEAT SENSING” RECEPTOR?
The direct heat-sensing or the perception of a non-thermal
chemical stimulus by non-neuronal cells such as a HSR stimulus,
resulting in the accumulation of HSPs, may be associated with
changes in the membrane state, especially the organization of the
membrane micro-domains, and the activation of a signal protein
such as calmodulin (Balogh et al., 2005).
Transient Receptor Potential (TRP) channels are members
of a large family of cationic channels that serve as major
players in sensory physiology, such as transduction of chemicals,
temperature, and mechanic stimuli (Török et al., 2014). TRP
channels that are known to be gated by warm temperatures are
TRPV1,2,3,4, and TRPM3. Among them the TRPV1, which is
expressed in nociceptors and gated by heat, low pH Capsaicin
(the active ingredient of the hot chili pepper), as well as by
endogenous lipids, is known to be activated in inflammatory pain
and hyperalgesia (Török et al., 2014).
Some studies have hypothesized that several TRP channels
sense changes in temperatures via changes in lipid bilayer
tension (Török et al., 2014) and that lipids have an important
modulatory role in indirect TRPs gating. It has been suggested
that thermodynamic changes in the lipid composition around
these channels can regulate their gating as well (Multhoff et al.,
1995).
There are several lipids that are known to modulate the TRP.
However, up to now, the molecular mechanism modulating the
temperature sensitivity of the TRP channels, is yet unknown.
However, it has been demonstrated that the C terminus of
the Transient Receptor Potential Vanilloid-1 (TRPV1) contains
modulatory domains capable of binding calmodulin in the
presence of bound Ca2+ ions (Jung et al., 2004).
TRPs are also sensitive to PIP2—which is an important
feature of cell signaling due to its high abundance in the
membrane and since it serves as a substrate for phospholipase
C (PLC). However, the regulation of TRPV1 by PIP2 seems to be
controversial: Although some studies have shown that activation
of TRPV1 does not require PIP2, others have demonstrated that
the addition of PIP2 can induce TRPV1 activation. It was also
shown that oxidation of linoleic acid and LPA, another enzymatic
product of phospholipids that is produced during inflammation
and tissue injury, can activate TRPV1 as well. The cholesterol
membrane content also plays a major role in the activity and
sensitivity of several TRP channels such as TRPV1 and TRPC3.
Hence, ameliorations of lipid compositions and sphingolipid
cholesterol signaling cascades during stress response or heat
shock were found to be correlated with Hsp production (Török
et al., 2014). Lipid membrane peroxidation was also found to
activate HSF1.We recently found that theremay be an alternative
mechanism for activating the HSR through the membrane
(Bromberg et al., 2013) (Figure 1). The use of Capsaicin or
resiniferatoxin (RTX), both agonists of TRPV1, resulted in
elevated levels of Hsp70, Hsp90, and Hsp25 in several epithelial
cells in addition to a high abundance of nuclear HSF1 and higher
HSF1 activity (Bromberg et al., 2013). In order to explore the
existence of such a mechanism, EGTA, a calcium blocker, was
added to the cells with or without heat shock treatment. Our
findings were similar to those observed in plants; the addition
of EGTA reduced heat-shock induced levels of Hsp70, Hsp90,
Hsp25, as well as nuclear HSF1, suggesting that the calcium
channels in mammals are involved in HSR regulation (Bromberg
et al., 2013).
However, as mentioned earlier, the possible heat sensing
membrane receptors as well as the downstream signaling
pathways are still elusive. Several pathways and/or molecules
are possible candidates. Activation of CaMKII, PI3-kinase,
and ERK1/2 by Ca2+ influx has been reported to potentiate
TRPV1 channel activity in vivo and in-vitro (Jung et al., 2004;
Zhuang et al., 2004; Clapham, 2007). It is also known that
phosphorylation of the TRPV1 channel by CaMKII can increase
TRPV1 binding to Capsaicin and that ERK activation in rat DRG
neurons occurs within 2 min after capsaicin application (Zhuang
et al., 2004). Other downstream effectors of TRPV1 related to
cellular cancer promoting pathways that may be associated with
ERK and Src (Dai et al., 2002; Hwang et al., 2010).
MODULATION OF
MEMBRANE-ASSOCIATED HEAT SHOCK
RECEPTOR- THE ROLE OF HEAT SENSING
CELLULAR PATHWAYS IN HEALTH AND
DISEASE
It has been well described that membrane Hsp70 positive tumor
cells are more resistant to irradiation than membrane Hsp70
negative cells (Murakami et al., 2015).
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FIGURE 1 | Here we propose an alternative “heatsensing” model in which exposure to heat or treatment with capsaicin resulted in HSR activation,
through TRPV1, by yet unknown interim cellular mediators (1) Capsazepine, a selective antagonist of TRPV1, abolishes the heat- or capsaicin-induced
activation of the HSR and the consequent accumulation of Hsp70, 90, and 25 chaperones. This model is an alternative to the current prevailing proposed
mechanism suggesting that under stress, misfolded proteins recruit HSF1-interacting Hsps thereby allowing HSF1 activation (2).
We have found that the addition of Capsaicin to breast cancer
(MCF-7) cells, induced Hsp70 expression in some membrane
areas (Bromberg et al., 2013).
We further demonstrated that in-vivo, TRPV1 was highly
abundant in septic rats treated with an adenovirus overexpressing
Hsp70 and that TRPV1 using co-immunoprecipitation, co-
precipitated with Hsp70 from lung tissue of rats. These data may
prove that during overexpression of Hsp70 or with the addition
of Capsaicin, Hsp70 possibly co-localizes to the membrane and
perhaps by that, regulates the HSR, an event that may occur in
cancer cells as well (Bromberg et al., 2013).
Capsaicin, the agonists for the TRPV1, also resulted
in elevated cytoplasmic levels of Hsp70, Hsp90, and
Hsp25 in diverse cancerous epithelial cells, such as colon
cancer cells (HT-29) and, as mentioned above, in MCF-7
cells.
Thus, we showed that the use of the membrane receptor
blockers Capsazepine or AMG-9810, TRPV1 antagonists, and
TRPV1 siRNA resulted in decreased heat shock proteins, Hsp70
and Hsp90 in cancer cells.
Therefore, we believe that a possible strategy to treat various
cancers could utilize substances known to regulate the HSR
through a membrane receptor capable of reducing the expression
of heat shock proteins such as Capsazepine or AMG-132 and
TRPV1 siRNA. Currently, we are exploring the consequences
or the downstream pathways involved in this phenomenon (Ito
et al., 2013).
TARGETING MEMBRANE AND
EXTRACELLULAR HSP70 – AN
ANTI-HSP70’S DIRECTED CANCER
THERAPY
As described earlier, cancer cells or tumors frequently
overexpress Hsp70 in the cytosol, but also present Hsp70
on their plasma membrane, as was found in our model as
well (Vígh et al., 1997; Vega et al., 2008; Wiech et al., 2012).
Membrane localization of Hsp70 in tumor cells is due to tumor-
specific lipid composition of the membrane; Hsp70 co-localizes
with the lipid raft glycolipidgloboyltriaosylceramide (Gb3)
(Multhoff et al., 1997), and associates with phosphatidylserine
(PS) which translocates from the inner to the outer plasma
membrane through the activation of the ATP and Ca2+ after
stress (Gehrmann et al., 2008).
The existence of membrane Hsp70 in tumor cells may also
imply that there is a release of Hsp70 in lipid vesicles—termed
exosomes (Schlegel and Williamson, 2001). Exosomes may fuse
with the plasma membrane of target cells (Gastpar et al.,
2005), transferring genetic material and signaling proteins, and
thus may stimulate tumor metastasis (Campanella et al., 2014).
Therefore, Hsps located on the surface of exosomes, secreted
by normal stressed or tumor cells may have a possible central
role in cell-to-cell communication (Gastpar et al., 2005). It was
found that incubation of cells with exosomes, increased the
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phosphorylation of Hsp70 with ERK1/2, and was negatively
regulated by caveolin-1 (Campanella et al., 2014). Extracellular
Hsp70 may also be considered to act as “danger signals,” in
modulating the cellular immune response (Svensson et al., 2013).
Morimoto et al. (Moseley, 2000) have recently suggested a
possible additional mechanism in which “Transcellular Factors”
(TSF) or “danger signals” may be transferred through specific
trans-cellular channels to adjacent cells, however, as a result
of this chaperone trans-cellular pathway, the HSR is inhibited,
or “shut-down” within the neighboring cells (Moseley, 2000).
Serum levels of liposomal Hsp70 might also predict the presence
of Hsp70 membrane-positive tumors. Studies have shown that
Hsp70 serum levels are significantly higher in cancer patients
compared to healthy individuals or patients with chronic
inflammation. But it was also found that Hsp70 translocates into
lysosomal membranes and by that stabilizes these membranes.
Stabilized lysosomal membranes are protected against apoptotic
stimuli, such as irradiation (Murakami et al., 2015).
Some cancer therapies such as thermo/radiotherapy could
induce necrosis within the central zone. Thus, since elevated
Heat shock protein levels can enhance tumor cell viability
and increase resistance, the peripheral or transitional zone of
sublethal hyperthermiamight undergo a recovery from reversible
injury, rendering this therapeutic approach inefficient.
However, rodent studies have indicated that irradiation was
associated with a reduction in Hsp70 serum levels (Van Oosten-
Hawle et al., 2013). Hence, Multhoff et al. proposed that serum
Hsp70 levels could provide in the future a useful biomarker and
a minimally invasive approach to predict the presence of tumors
and to monitor the outcome of a therapy (Multhoff et al., 2015).
However, Hsp70 membrane expression, or exosomal Hsp70
on highly aggressive tumor cells could also activate NK cells
(Multhoff et al., 2015):
Following irradiation, there is direct killing of cancer cells
which is mediated by DNA damage, although this process also
initiates effects that can stimulate the T and NK cell immune
responses (Bayer et al., 2014). NK cells, which are related to the
innate immune system, are also responsible for the first line of
defense against malignantly transformed cells and tumors. It is
known that NK cells can recognize membrane-bound Hsp70 on
tumor cells (Wattenberg et al., 2014). Multhoff et al. (2015), have
demonstrated that an incubation of NK cells with the Hsp70
protein or an Hsp70-derived peptide (TKD) with the addition of
low doses of interleukin-2 (IL-2) for several days (Multhoff et al.,
1998), can stimulate the proliferative and migration of NK cells
against membrane- hsp70 positive tumor cells (Multhoff et al.,
1998; Wattenberg et al., 2014).
These findings might have a significant future clinical
relevance for irradiation therapy that could be improved by
combining it with immunotherapy targeting membrane Hsp70.
THE IMPORTANCE OF THE PLASMA
MEMBRANE IN CANCER THERAPY
The “cross talk” between the HSR, membranes, and intracellular
pathways opens a new field that may help understand the
mechanisms of missfolding diseases, such as aging and cancer.
The plasma membrane fluidity state and its role in the
pathological conditions of the cells, such as in cancer, aging, or
stress response serves as the first guard against such stressors and
connects between the extracellular and the intracellular signals.
“Lipid therapy” as suggested by Vigh et al. in which a molecule
affects membrane lipid re-organization maybe of therapeutic
potential since such membrane fluidizers were found to enhance
heat shock geneexpression in diseased cells without affecting
healthy cells (Multhoff et al., 2001; Vigh et al., 2007).
Lipid therapy offers a possible strategy of regulating the
fluidity of the membranes and modulating Hsps activities
within the membrane. Hence, lipid therapy and antagonists of
membrane-bound receptors, such as TRPV1, could allow us to
modulate the heat sensing route of cancer cells, hence curtailing
their pro-survival mechanisms.
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